Nano-Medicine for Treatment of Tuberculosis, Promising Approaches Against Antimicrobial Resistance

Even though the number of effective anti-tuberculosis or anti-mycobacterial agents is increasing, a large number of patients experience severe side effects as a result of these drugs. This hurts the patients’ well-being and quality of life. Tumor cells that survive treatment modalities can become ch...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Current microbiology Ročník 81; číslo 10; s. 326
Hlavní autori: Mobed, Ahmad, Alivirdiloo, Vahid, Gholami, Sarah, Moshari, Amirreza, Mousavizade, Azamsadat, Naderian, Ramtin, Ghazi, Farhood
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: New York Springer US 01.10.2024
Springer Nature B.V
Predmet:
Animals
antibiotic resistance
Antimicrobial resistance
Antitubercular Agents - pharmacology
Antitubercular Agents - therapeutic use
Biomedical and Life Sciences
Biotechnology
Chemotherapy
Drug delivery
Drug Delivery Systems - methods
Drug resistance
Drug Resistance, Bacterial
Drugs
Humans
Life Sciences
Microbiology
Mycobacterium tuberculosis - drug effects
nanomedicine
Nanomedicine - methods
Nanoparticles
Nanoparticles - chemistry
neoplasms
Quality of life
Review
Side effects
Topical application
Tuberculosis
Tuberculosis - drug therapy
Tuberculosis - microbiology
Tumor cells
Well being
ISSN:0343-8651, 1432-0991, 1432-0991
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Even though the number of effective anti-tuberculosis or anti-mycobacterial agents is increasing, a large number of patients experience severe side effects as a result of these drugs. This hurts the patients’ well-being and quality of life. Tumor cells that survive treatment modalities can become chemotherapy resistant at the molecular level. Furthermore, negative effects on normal cells occur concurrently. Strategies that minimize the negative effects on normal cells while efficiently targeting infected cells are required. Nanotherapies, according to recent research, may be one option in this direction. The present study differs from previously published review studies as it concentrates on examining the most recently developed nanoparticles for anti-mycobacterial purposes. Such novel approaches have the potential to reduce harmful side effects and improve patients’ health prognoses. Current paper provides a comprehensive analysis of recent advances in nanotherapy systems for the pulmonary delivery of anti-tuberculous drugs. In addition, to low-priced and convenient alternatives for pulmonary delivery, different types of NPs for oral and topical application were also deliberated and summarized in this review. Graphical Abstract
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0343-8651
1432-0991
1432-0991
DOI:10.1007/s00284-024-03853-z